Literature DB >> 31522482

Beware mis-representation of PRODIGE 7: danger of throwing out the cytoreductive surgery baby with the hyperthermic intraperitoneal chemotherapy bathwater.

Cherry E Koh1,2,3,4, Nabila Ansari1,2, David Morris5,6, Brendan Moran1,7.   

Abstract

Year:  2019        PMID： 31522482     DOI： 10.1111/ans.15424

Source DB:  PubMed          Journal:  ANZ J Surg        ISSN： 1445-1433            Impact factor:   1.872


× No keyword cloud information.
  5 in total

1.  Pharmacologic Effects of Oxaliplatin Instability in Chloride-Containing Carrier Fluids on the Hyperthermic Intraperitoneal Chemotherapy to Treat Colorectal Cancer In Vitro and In Vivo.

Authors:  Eun Jung Park; Junhyun Ahn; Sharif Md Abuzar; Kyung Su Park; Sung-Joo Hwang; Seung Hyuk Baik
Journal:  Ann Surg Oncol       Date:  2022-08-30       Impact factor: 4.339

2.  GECOP-MMC: phase IV randomized clinical trial to evaluate the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) with mytomicin-C after complete surgical cytoreduction in patients with colon cancer peritoneal metastases.

Authors:  Fernando Pereira; Angel Serrano; Israel Manzanedo; Estibalitz Pérez-Viejo; Santiago González-Moreno; Luis González-Bayón; Alvaro Arjona-Sánchez; Juan Torres; Isabel Ramos; Maria E Barrios; Pedro Cascales; Rafael Morales; Enrique Boldó; Alfonso García-Fadrique; Xabier Arteaga; Alberto Gutierrez-Calvo; Susana Sánchez-García; Enrique Asensio; Cesar P Ramírez; Manuel Artiles; Javier Vaqué; Pedro A Parra; Pedro Villarejo; Cristóbal Muñoz-Casares; Estrella Turienzo; Alicia Calero; Isabel Jaén Torrejimeno; Isabel Prieto; Julio Galindo; Vicente Borrego; Manuel E Marcello; Cristina Rihuete; Joaquin Carrasco; Luis Gomez-Quiles
Journal:  BMC Cancer       Date:  2022-05-12       Impact factor: 4.638

3.  Peritoneal metastases from colorectal cancer belong to Consensus Molecular Subtype 4 and are sensitised to oxaliplatin by inhibiting reducing capacity.

Authors:  Jamila Laoukili; Alexander Constantinides; Emma C E Wassenaar; Sjoerd G Elias; Danielle A E Raats; Susanne J van Schelven; Jonathan van Wettum; Richard Volckmann; Jan Koster; Alwin D R Huitema; Simon W Nienhuijs; Ignace H J T de Hingh; René J Wiezer; Helma M U van Grevenstein; Inne H M Borel Rinkes; Djamila Boerma; Onno Kranenburg
Journal:  Br J Cancer       Date:  2022-02-22       Impact factor: 9.075

4.  Place of hyperthermic intraperitoneal chemotherapy in the armament against pancreatic adenocarcinoma: A survival, mortality and morbidity systematic review.

Authors:  Andreas Larentzakis; Evangelos Anagnostou; Konstantinos Georgiou; Gavriella-Zoi Vrakopoulou; Constantinos G Zografos; Georgios C Zografos; Konstantinos G Toutouzas
Journal:  Oncol Lett       Date:  2021-02-03       Impact factor: 2.967

5.  Results of systematic second-look surgery plus hipec in perforated or pt4 colon cancer. Case series.

Authors:  Ángel Serrano Del Moral; Estíbalitz Pérez Viejo; Israel Manzanedo Romero; Fernando Pereira Pérez
Journal:  Ann Med Surg (Lond)       Date:  2021-01-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.